Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Mereo Biopharma Group (MREO)

Annual Return

Over the past 3 years, MREO has had an average annual return of -38.22%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, MREO has had an average annual return of -35.69%, underperforming the benchmark SPY, which returned +12.55% annual.

Since Apr 24, 2019, MREO has had an average annual return of -34.43%, underperforming the benchmark SPY, which returned +15.43% annual.

20262025202420232022202120202019
-26.68%-88.10%+51.52%+207.97%-53.13%-55.30%+9.16%-49.54%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+5.62%-15.81%-10.88%-18.70%+28.09%-7.56%-3.89%-26.68%
2025-14.00%-20.28%-6.26%+15.14%-16.99%+26.03%-37.63%+1.19%+20.45%-7.76%-1.57%-77.72%-88.10%
2024+64.07%+0.26%-13.15%-7.58%+13.13%+4.33%+12.78%+15.51%-12.36%+2.44%-14.37%-2.90%+51.52%
2023+24.70%-4.59%-20.76%+85.20%-22.88%+30.69%+0.74%+3.03%-5.83%+55.42%+4.21%+10.54%+207.97%
2022-18.16%-5.31%-9.70%-44.63%-18.45%+121.47%+8.07%-0.86%-28.22%+16.08%-21.20%-4.79%-53.13%
2021-24.02%+43.01%-13.37%+5.32%-7.87%-3.06%-18.93%+8.55%-13.26%-7.04%-21.76%-9.08%-55.30%
2020-48.71%+9.97%-43.50%+31.09%-7.31%+140.94%-6.86%+4.90%-12.37%-9.55%+2.96%+46.72%+9.16%
2019-13.85%-24.11%-40.70%+3.17%+41.15%-18.79%-1.50%-19.26%+38.40%-49.54%

Drawdown analysis of Mereo Biopharma Group (MREO)

The maximum drawdown for the MREO was -96.35%, occurring on May 6, 2026. This drawdown has not yet recovered.

The current MREO drawdown is -95.30%.

Since Apr 24, 2019 MREO has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-96.35%Apr 24, 20191768May 6, 2026OngoingOngoingOngoing